The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Biotech leaders at a Stanford symposium normally focused on the future couldn’t help but grapple with a present clouded by ...

Vinay Prasad, a skeptic of mainstream medicine, is now a top FDA official. Change is coming for some drugmakers, one way or ...

The 27,000-square-foot center will serve as a hub for advanced livestock reproduction research, education, and outreach, ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

As a descendant of an Indigenous Amazonian tribe, Maria Astolfi was concerned about research she conducted as a graduate ...

Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...

Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a ...

PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech” or the "Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious ...

Since the passage of the Inflation Reduction Act, at least 49 research programs and 24 drugs have been discontinued according to Incubate's Life Sciences Investment Tracker. Legislation like the ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...